Search by Drug Name or NDC

    NDC 76420-0621-90 Lansoprazole 30 mg/1 Details

    Lansoprazole 30 mg/1

    Lansoprazole is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Asclemed USA, Inc.. The primary component is LANSOPRAZOLE.

    Product Information

    NDC 76420-0621
    Product ID 76420-621_06f23716-6fa8-7294-e063-6394a90a0db9
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Lansoprazole
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lansoprazole
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 30
    Active Ingredient Units mg/1
    Substance Name LANSOPRAZOLE
    Labeler Name Asclemed USA, Inc.
    Pharmaceutical Class Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207394
    Listing Certified Through 2024-12-31

    Package

    NDC 76420-0621-90 (76420062190)

    NDC Package Code 76420-621-90
    Billing NDC 76420062190
    Package 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-621-90)
    Marketing Start Date 2023-10-05
    NDC Exclude Flag N
    Pricing Information N/A